Eculizumab exposure in children and young adults: indications, practice patterns, and outcomes—a Pediatric Nephrology Research Consortium study

Melissa Muff-Luett, Keia R. Sanderson, Rachel M. Engen, Rima S. Zahr, Scott E. Wenderfer, Cheryl L. Tran, Sheena Sharma, Yi Cai, Susan Ingraham, Erica Winnicki, Donald J. Weaver, Tracy E. Hunley, Stefan G. Kiessling, Meredith Seamon, Robert Woroniecki, Yosuke Miyashita, Nianzhou Xiao, Abiodun A. Omoloja, Sarah J. Kizilbash, Asif MansuriMahmoud Kallash, Yichun Yu, Ashley K. Sherman, Tarak Srivastava, Carla M. Nester

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)2349-2360
Number of pages12
JournalPediatric Nephrology
Volume36
Issue number8
DOIs
StatePublished - Aug 2021

ASJC Scopus Subject Areas

  • Pediatrics, Perinatology, and Child Health
  • Nephrology

Keywords

  • Atypical hemolytic uremic syndrome
  • Eculizumab
  • Hemolytic uremic syndrome
  • Pediatric
  • Atypical hemolytic-uremic syndrome
  • Hemolytic-uremic syndrome
  • Off-label use (Drugs)
  • Pediatric nephrology

Disciplines

  • Medical Specialties
  • Medicine and Health Sciences
  • Pediatrics

Cite this